Media

Regulatory update from US Food and Drug Administration

Pulmonx Announces Long-Term Follow-Up Data Confirming Significant Benefits of Zephyr Valve for Patients with Severe COPD/Emphysema

SynOx Therapeutics Strengthens Team with appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer

Aprea Therapeutics Announces Positive Results from Phase 2 Trial of Eprenetapopt + Azacitidine for Post-Transplant Maintenance Therapy in TP53 Mutant MDS and AML

Pulmonx to Report Second Quarter 2021 Financial Results on August 3, 2021

BONESUPPORT HOLDING AB (PUBL) – PUBLISHES Q2 2021 INTERIM REPORT

Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS® (dichlorphenamide) for the Treatment of Primary Periodic Paralysis in Muscle & Nerve

BONESUPPORT HOLDING AB (publ) – Interim Report Q2 2021 Invitation to conference call and webcast